Skip to main content

Table 1 PPI activities in PROUD

From: “PROUD to have been involved”: an evaluation of participant and community involvement in the PROUD HIV prevention trial

 

PPI Activity

Area of impact (based on PiiAF [11])

1.

Membership of e-group to design trial (> 10 community members)

• Agenda

• Research design

2.

Membership of advisory committees:

• Community engagement group (CEG) (involved in development of study documentation, recruitment strategies, dissemination plans and messages). The group met approximately every 6 months (11 community members)

• Trial steering committee (trial oversight). The group met approximately every 6 months. (3 community members, including co-chair)

• Trial management group (research design and delivery, analysis of data, writing up and dissemination). The group met approximately every month. (All 11 CEG members invited and provided with minutes)

• Independent data monitoring committee (trial oversight). The group met three times. (1 community members)

• Research design and delivery

• Ethics

• Recruitment

• Data collection

• Analysis of data (interpretation)

• Writing-up

• Dissemination

3.

Extended Community Engagement Meeting in June 2013 at the Medical Research Council in London – this involved people working in the media or on dating sites (8 community members)

• Recruitment

4.

Participant involvement meeting:

a. 12th November 2013: ‘Future Options for PROUD’ by teleconference and webinar (8 participants)

b. 19th March 2014: ‘Future HIV prevention research priorities’ at Terrence Higgins Trust in London (17 participants)

c. 9th & 11th September 2014: ‘Study design and data collection tools for a larger PROUD trial’ at the Medical Research Council (in London on 9th and by teleconference on 11th September) (12 participants)

d. 16th & 18th February 2015: ‘PROUD Study Results’ at the following locations:

 i. Manchester: 16th February (5 participants)

 ii. London: 16th February (24 participants)

 iii. Brighton: 16th February (14 participants)

 iv. Sheffield: 18th February (4 participants)

e. 25th June 2015: ‘World Health Organisation PrEP Implementation Guidelines’ at 56 Dean Street clinic (11 participants)

f. February 2017: review of the interpretation of an analysis of self-reported depression during the study (13 participants online)

• Agenda (future research)

• Research design (future trial)

• Data collection

• Analysis of data (interpretation)

• Dissemination

5.

Involved in communicating results of the PROUD study, from February 2015 onwards, including:

• Getting involved with making the PROUD film documentary (2 community members and 3 participants)

• Attending showings and panel discussions of the film (various locations around the UK)

• Speaking to the media or providing information to the media (> 5 community members and > 5 participants)

• Getting involved in the World AIDS Day twitter event (December 2015) (1 community members and 1 participants)

• Speaking to groups as a participant or community representative of PROUD (> 5 community members and > 3 participants) (various locations around the UK)

• Getting involved in advocacy as a PROUD participant (for example through United4PrEP) (> 5 community members and > 5 participants)

• Dissemination

6.

Reviewed a new PROUD study questionnaire by email in November/December 2015 (6 community members and 6 participants)

• Research design and delivery